Founders Capital Management Ocular Therapeutix, Inc Transaction History
Founders Capital Management
- $154 Million
- Q1 2025
A detailed history of Founders Capital Management transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Founders Capital Management holds 2,000 shares of OCUL stock, worth $18,180. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,000
Previous 2,000
-0.0%
Holding current value
$18,180
Previous $17,000
11.76%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding OCUL
# of Institutions
207Shares Held
135MCall Options Held
426KPut Options Held
119K-
Deep Track Capital, LP Greenwich, CT14.3MShares$130 Million3.66% of portfolio
-
Summer Road LLC West Palm Beach, FL13.9MShares$126 Million98.53% of portfolio
-
Vr Adviser, LLC New York, NY12.8MShares$116 Million22.59% of portfolio
-
Black Rock Inc. New York, NY11.5MShares$105 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.36MShares$76 Million0.0% of portfolio
About OCULAR THERAPEUTIX, INC
- Ticker OCUL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,966,896
- Market Cap $700M
- Description
- Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...